Takeda Pharmaceutical (TAK) earnings, Jul 30, 2026: EPS +94%, stock −2.8%
In brief
Takeda Pharmaceutical reported on Jul 30, 2026. Earnings per share changed +94% year over year, 33.2% above the estimate; revenue +6%. The stock opened with a −4.0% gap and closed the day −2.8% (Jul 30, 2026). The stock is now 2.5% below its 52-week high, +55.9% over 12 months. Next report: Jan 28, 2027.
EPS vs estimate+33.2%
EPS, YoY+94%
Revenue, YoY+6%
Gap · day−4.0% · −2.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −4.0% | −2.8% |
Next-quarter estimates, ratings and the TAK chart are in the terminal.
Open the terminalFAQ
When is Takeda Pharmaceutical's next earnings report?
Jan 28, 2027. The date comes from daily data and is corrected if the company moves it.
How did Takeda Pharmaceutical stock react to the report?
Opening gap −4.0%, day's result −2.8%.
Did Takeda Pharmaceutical's earnings grow?
Earnings per share rose 94% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.